Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC trial

被引：0
作者：
Jonathan Calkwood
Bruce Cree
Heidi Crayton
Daniel Kantor
Brian Steingo
Luigi Barbato
Ron Hashmonay
Neetu Agashivala
Kevin McCague
Nadia Tenenbaum
Keith Edwards
机构：
[1] Minneapolis Clinic of Neurology,
[2] University of California San Francisco,undefined
[3] MS Center of Greater Washington,undefined
[4] Neurologique,undefined
[5] Fort Lauderdale MS Center,undefined
[6] Novartis Pharmaceuticals Corporation,undefined
[7] MS Center of Northeastern New York,undefined
来源：
BMC Neurology | / 14卷
关键词：
36-item Short-Form Health Survey (SF-36); Beck Depression Inventory-II (BDI-II); Clinical Global Impressions of Improvement (CGI-I); Fatigue Severity Scale (FSS); Fingolimod; FTY720; Multiple sclerosis; Treatment Satisfaction Questionnaire for Medication (TSQM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 237 条
  • [1] Brinkmann V(2010)Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat Rev Drug Discov 9 883-897
  • [2] Billich A(2005)Immunology of multiple sclerosis Annu Rev Immunol 23 683-747
  • [3] Baumruker T(1989)The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course Brain 112 1419-1428
  • [4] Heining P(2002)Quality of life in patients with multiple sclerosis: the impact of fatigue and depression J Neurol Sci 205 51-58
  • [5] Schmouder R(2009)A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events Curr Med Res Opin 25 77-92
  • [6] Francis G(2009)Factors that influence adherence with disease-modifying therapy in MS J Neurol 256 568-576
  • [7] Aradhye S(2011)Interferon therapy in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of the comparative trials J Neurol Sci 302 96-105
  • [8] Burtin P(2010)Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis N Engl J Med 362 402-415
  • [9] Sospedra M(2010)A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 387-401
  • [10] Martin R(2011)Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study Mult Scler 17 1341-1350
12345678910